Northwest Biotherapeutics (NWBO) News Today → I’m afraid WWIII is a very real possibility (From Porter & Company) (Ad) Free NWBO Stock Alerts $0.47 -0.01 (-2.10%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | americanbankingnews.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200 Day Moving Average of $0.63March 21, 2024 | prnewswire.comNorthwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of DirectorsMarch 2, 2024 | ft.com‘Spoofing’ case might draw back curtain on high-speed trading firmsFebruary 29, 2024 | uk.finance.yahoo.comNorthwest Biotherapeutics, Inc. (NWBO)February 23, 2024 | benzinga.comNorthwest Biotherapeutics Stock (OTC:NWBO), Short Interest ReportFebruary 7, 2024 | finance.yahoo.comNorthwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory CertificationDecember 22, 2023 | msn.comNorthwest Biotherapeutics submits marketing application to UK MHRA for DCVax-LDecember 21, 2023 | finanznachrichten.deNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For GlioblastomaDecember 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For GlioblastomaNovember 22, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization ApplicationOctober 31, 2023 | morningstar.comNorthwest Biotherapeutics Inc NWBOOctober 14, 2023 | msn.comNorthwest Bio: Another Small Filing DelayOctober 13, 2023 | seekingalpha.comNW Bio dips on announcing delay in submission of marketing application for DCVaxOctober 13, 2023 | marketwatch.comNorthwest Biotherapeutics Shares Slide on Application DelayOctober 13, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization ApplicationSeptember 12, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory BoardAugust 17, 2023 | msn.comNorthwest Bio: Is There Ever Going To Be A Right Time?August 6, 2023 | usnews.comNorthwest Missouri State UniversityAugust 4, 2023 | health.usnews.comNorthwest HospitalJuly 15, 2023 | thestreet.comWhy Northwest Bio Is Shunned by Savvy Health Care InvestorsJune 19, 2023 | pnj.comThree rounds of severe weather expected over the next 24 hours for Northwest FloridaJune 13, 2023 | health.usnews.comHCA Houston Healthcare NorthwestMay 27, 2023 | finance.yahoo.comNWBO - Northwest Biotherapeutics, Inc.May 9, 2023 | thestreet.comNorthwest Bio Warns FDA May Throw Out Phase III Brain Cancer StudyApril 13, 2023 | health.usnews.comNorthwest Medical Center-TucsonMarch 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. FacilityMarch 11, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That It Has No Banking Relationship With SVBMarch 9, 2023 | msn.comNorthwest Bio in $11M loan agreement with Streeterville CapitalJanuary 6, 2023 | bizjournals.comBrown-Lifespan researchers advance new vaccine to treat brain cancerJanuary 6, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023December 1, 2022 | ft.comUS cancer drug company accuses market makers of stock spoofingDecember 1, 2022 | benzinga.comCohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market ManipulationDecember 1, 2022 | finance.yahoo.comCancer drug company accuses US market makers of stock spoofingNovember 23, 2022 | seekingalpha.comNorthwest Biotherapeutics: Data Is Done, Just Wait For ApprovalNovember 18, 2022 | finance.yahoo.comNorthwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for GlioblastomaOctober 18, 2022 | seekingalpha.comNorthwest Biotherapeutics: Biopharma's Promising DelinquentOctober 10, 2022 | usnews.comUS Officials Seek Public Comment on Pacific Northwest TrailSeptember 15, 2022 | seekingalpha.comNWBO Northwest Biotherapeutics, Inc.August 23, 2022 | finance.yahoo.comNorthwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRAAugust 10, 2022 | apnews.comNorthwest Biotherapeutics: Q2 Earnings SnapshotJuly 6, 2022 | finance.yahoo.comNorthwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK FacilityMay 10, 2022 | seekingalpha.comNorthwest Bio plunges after late-stage data for lead candidate in brain cancerMay 10, 2022 | finance.yahoo.comPresentation About Phase 3 Trial of DCVax®-L for Glioblastoma Today At New York Academy of Sciences To Be Available Online As WellMay 5, 2022 | finanznachrichten.deNorthwest Biotherapeutics: Presentation About Phase 3 Trial of DCVax-L for Glioblastoma To Be Made At New York Academy Of SciencesMay 4, 2022 | finance.yahoo.comPresentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of SciencesFebruary 17, 2022 | seekingalpha.comNorthwest stock rises 9% as company begins cancer vaccine production at UK facilityFebruary 17, 2022 | finance.yahoo.comNorthwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK FacilityDecember 30, 2021 | news.yahoo.comDEDUCED RECKONING: Northwest Biotherapeutics receives license for Sawston UK plantDecember 5, 2021 | seekingalpha.comNorthwest Biotherapeutics secures $15M financing on stock purchase rightsNovember 29, 2021 | finance.yahoo.comNorthwest Biotherapeutics Announces $15 Million Financing Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. NWBO Media Mentions By Week NWBO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWBO News Sentiment▼0.920.50▲Average Medical News Sentiment NWBO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWBO Articles This Week▼20▲NWBO Articles Average Week Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STOK News PHAT News ORIC News AVBP News PHGUF News CDMO News SLN News HROW News SVRA News ZYME News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWBO) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.